Psittacosis: An Underappreciated and Often Undiagnosed Disease

Zygmunt F Dembek1, Jerry L Mothershead2, Akeisha N Owens3

  • 1Battelle Memorial Institute, Support to DTRA Technical Reachback, Columbus, OH 43201, USA.

PubMed

Insights

Chlamydia psittaci causes psittacosis, an underappreciated infectious disease with potential for person-to-person spread. Increased public health awareness and reporting are recommended to address this emerging threat.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Chlamydia psittaci is an underappreciated bacterial agent responsible for psittacosis.
  • The disease is not widely recognized by healthcare practitioners and public health officials.
  • Recent outbreaks show person-to-person transmission, highlighting its public health significance.

Purpose of the Study:

  • To review the pathogen Chlamydia psittaci and the disease psittacosis.
  • To examine the potential for genetic manipulation of C. psittaci into a more dangerous pathogen.
  • To assess current global disease incidence and recommend public health interventions.

Main Methods:

  • Literature review of Chlamydia psittaci and psittacosis.
  • Analysis of recent disease surveys and transmission patterns.
  • Evaluation of genetic manipulation potential and public health reporting strategies.

Main Results:

  • Chlamydia psittaci infections can lead to significant psittacosis outbreaks.
  • Person-to-person transmission of C. psittaci has been documented.
  • Australia, Germany, and the UK currently report the highest incidences of human disease.

Conclusions:

  • Universal public health reporting of C. psittaci and psittacosis is recommended.
  • Increased public health awareness campaigns are crucial for disease control.
  • The potential for C. psittaci genetic modification warrants further investigation.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
314
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
253
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
865
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
37
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K